Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Benzinga Pro's Top 5 Stocks To Watch For Monday, Dec. 14, 2020: MRNA, LEN, WISH, RMG, GOSS

Author: Benzinga Newsdesk | December 14, 2020 09:31am

Today's 5 Stock Ideas: 

  • Moderna (MRNA) - Shares traded higher with the broader stock market following news late Friday COVID-19 vaccine from Pfizer (PFE) and BioNTech (BNTX) received authorization from the FDA. Moderna will face its own FDA panel on Dec. 17 regarding the emergency use authorization application it has filed for its coronavirus vaccine candidate 
  • Lennar (LEN) - Will report quarterly earnings after market close on Wednesday. Housing data out on Wednesday and Thursday of this week could also drive price action in homebuilding stocks.
  • Context Logic (WISH) - An IPO expected to open for trade on Wednesday. Context Logic is the owner of e-commerce platform, Wish.
  • RMG Acquisition Corp. (RMG) - Electric vehicle batter play, Romeo Power, is expected to merge with RMG Acquisition before year end. Romeo Power CEO, Lionel Selwood, will appear on Benzinga's "SPACs Attack" show Monday morning. Click here to tune in to the 11 a.m. EST interview.
  • Gossamer Bio (GOSS) - Will release initial results from the ongoing Phase 1b clinical trial of GB002, its treatment candidate for pulmonary arterial hypertension. Expect results Tuesday afternoon.

Posted In: BNTX GOSS LEN MRNA PFE RMG WISH